+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Amgen Inc. - logo

Amgen is an international biotechnology company based in California, USA. Amgen is committed to using their experience in human genetics and biologics manufacturing to create innovative treatments for life threatening diseases particularly in areas of unmet medical need where limited treatment options exist. Amgen manufactures a wide range of therapeutic products including Aranesp, Corlanor, Neulasta and Prolia.

From
From
US Bispecific Antibodies Market & Clinical Pipeline Insight 2028 - Product Thumbnail Image

US Bispecific Antibodies Market & Clinical Pipeline Insight 2028

  • Drug Pipelines
  • August 2023
  • 580 Pages
  • United States
From
China Bispecific Antibodies Market and Clinical Pipeline Insight 2028 - Product Thumbnail Image

China Bispecific Antibodies Market and Clinical Pipeline Insight 2028

  • Drug Pipelines
  • August 2023
  • 400 Pages
  • China
From
From
From
Breast Cancer Monoclonal Antibodies Market Report 2026 - Product Thumbnail Image

Breast Cancer Monoclonal Antibodies Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
Esophageal Cancer Market Report 2026 - Product Thumbnail Image

Esophageal Cancer Market Report 2026

  • Report
  • February 2026
  • 250 Pages
  • Global
From
From
From
Chronic Spontaneous Urticaria - Pipeline Insight, 2025 - Product Thumbnail Image

Chronic Spontaneous Urticaria - Pipeline Insight, 2025

  • Clinical Trials
  • July 2025
  • 80 Pages
  • Global
From
Celiac Disease - Pipeline Insight, 2025 - Product Thumbnail Image

Celiac Disease - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 80 Pages
  • Global
From
Wearable Injectors Market - Forecasts from 2025 to 2030 - Product Thumbnail Image

Wearable Injectors Market - Forecasts from 2025 to 2030

  • Report
  • October 2025
  • 114 Pages
  • Global
From
From
From
Loading Indicator